查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1799063

全球经皮血氧仪系统市场

Transcutaneous Oximetry Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 282 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球经皮血氧仪市场规模将达到 1.82 亿美元

全球经经皮血氧仪市场规模预计在2024年为1.331亿美元，到2030年将达到1.82亿美元，在2024-2030年的分析期间内，复合年增长率为5.4%。週边血管疾病应用是本报告分析的细分领域之一，预计其复合年增长率为6.6%，到分析期结束时规模将达到9,040万美元。糖尿病足溃疡应用领域在分析期间的复合年增长率预计为3.4%。

美国市场规模估计为 3,630 万美元，中国市场预计复合年增长率为 8.7%

美国经皮血氧仪市场规模预计在2024年达到3,630万美元。作为世界第二大经济体，中国预计到2030年市场规模将达到3,690万美元，在2024年至2030年的分析期间内，复合年增长率为8.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.5%和5.4%。在欧洲，预计德国市场的复合年增长率为3.5%。

全球经皮血氧仪系统市场—主要趋势与驱动因素摘要

经皮血氧测定係统如何指导临床决策？

经皮血氧仪 (TcPO2) 系统使用连接在皮肤上的加热探头持续测量毛细血管中扩散的氧气浓度。这些非侵入式设备在伤口护理、周边动脉疾病评估、高压氧疗法和移植物监测中至关重要，无需反覆抽血即可深入了解组织灌注。此类即时数据使临床医生能够评估癒合潜力、调整氧气疗法并预测溃疡风险。

哪些创新可以提高 TcPO2 的准确性和易用性？

最新的 TcPO2 系统采用快速加热电容式感测器，可在数秒内稳定，从而缩短校准时间。无线蓝牙连接可远端监控并与医院资讯系统整合。感测器垫片现已包含一次性黏性膜，可减少交叉污染，并免除患者之间重新校准的需要。先进的演算法可根据环境温度和皮肤厚度自动调整，从而提高不同患者群体的测量精度。

在哪些临床环境下需要进行经皮血氧测定？

伤口管理中心使用 TcPO2 对溃疡进行分期、评估其癒合潜力并优化治疗强度。血管外科团队在肢体血管重组手术的追踪中使用 TcPO2。在高压氧气疗法中，TcPO2 会追踪治疗前、治疗中和治疗后的组织氧饱和度，以帮助调整压力通讯协定。儿科和新生儿加护病房会监测高风险婴儿的灌注情形。患有慢性伤口和周边血管疾病的居家照护护理人员使用可携式系统来追踪两次预约之间的治疗进展。

是什么推动了 TcPO2 系统市场的成长？

经皮血氧仪市场的成长动力源于慢性伤口（尤其是糖尿病足溃疡）发病率的上升、对保肢策略的重视以及非侵入性诊断工具的日益普及。临床指引支持透过灌注测量进行血管决策。该技术的微型化和无线功能有助于将其融入门诊护理。成本效益分析表明，该技术可减少截肢和住院时间，从而鼓励其在基层和专科机构广泛采用报销制度。

部分

应用（週边血管疾病应用、糖尿病足溃疡应用、早产应用、其他应用）、最终用户（医院最终用户、诊所最终用户、其他最终用户）

受访公司范例

  • Advin Healthcare
  • Baxter International
  • Cephalon（Teva subsidiary）
  • Diabetik Foot Care India
  • ELCAT GmbH
  • GE Healthcare
  • HUMARES GmbH
  • ICU Medical
  • MedicaP GmbH
  • Medtronic plc
  • Nihon Kohden
  • Nonin Medical Inc
  • Perimed AB
  • Philips Healthcare
  • Radiometer Medical ApS
  • SenTec AG
  • Shinse Electronics Group
  • Sophysa Ltd
  • Teva Pharmaceutical（Cephalon）
  • Vittamed

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP39445

Global Transcutaneous Oximetry Systems Market to Reach US$182.0 Million by 2030

The global market for Transcutaneous Oximetry Systems estimated at US$133.1 Million in the year 2024, is expected to reach US$182.0 Million by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Peripheral Vascular Disorders Application, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$90.4 Million by the end of the analysis period. Growth in the Diabetic Foot Ulcers Application segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$36.3 Million While China is Forecast to Grow at 8.7% CAGR

The Transcutaneous Oximetry Systems market in the U.S. is estimated at US$36.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$36.9 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Transcutaneous Oximetry Systems Market - Key Trends & Drivers Summarized

How Do Transcutaneous Oximetry Systems Guide Clinical Decisions?

Transcutaneous oximetry (TcPO2) systems employ heated probes adhered to the skin to continuously measure oxygen tension diffusing from capillaries. These non-invasive devices are essential in wound care, peripheral artery disease assessments, hyperbaric therapy, and graft monitoring, providing insights into tissue perfusion without repeated blood draws. Such real-time data allows clinicians to evaluate healing potential, adjust oxygen therapy, and predict ulcer risk-especially in diabetic or vascular-compromised patients.

What Innovations Elevate TcPO2's Accuracy and Usability?

Modern TcPO2 systems feature rapid-heating capacitive sensors that stabilize within seconds, reducing calibration time. Wireless Bluetooth connectivity enables remote monitoring and integration with hospital information systems. Sensor pads now include disposable adhesive membranes that reduce cross-contamination and eliminate recalibration between patients. Advanced algorithms auto-adjust for ambient temperature and skin thickness, enhancing measurement precision across diverse patient populations.

Which Clinical Environments Depend on Transcutaneous Oxygen Measurement?

Wound management centers rely on TcPO2 to stage ulcers and assess the likelihood of healing, optimizing treatment intensity. Vascular surgery teams use it during limb revascularization follow-up. In hyperbaric oxygen therapy, TcPO2 tracks tissue saturation before, during, and after treatments-helping tailor pressure protocols. Pediatric and neonatal ICUs monitor perfusion in at-risk infants. Home-care providers for chronic wounds or peripheral vascular disease patients leverage portable systems to track progress between clinical visits.

What Is Powering TcPO2 Systems’ Market Growth?

The growth in the transcutaneous oximetry market is driven by rising chronic wound incidence-particularly diabetic foot ulcers-greater emphasis on limb salvage strategies, and increasing adoption of non-invasive diagnostic tools. Clinical guidelines support perfusion measurement for vascular decision-making. Technological miniaturization and wireless capabilities enhance ambulatory care integration. Cost-efficiency analyses illustrate reduced amputations and hospital stays, encouraging broader reimbursement adoption in primary and specialist settings.

SCOPE OF STUDY:

The report analyzes the Transcutaneous Oximetry Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application, Other Applications); End-User (Hospitals End-User, Clinics End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Advin Healthcare
  • Baxter International
  • Cephalon (Teva subsidiary)
  • Diabetik Foot Care India
  • ELCAT GmbH
  • GE Healthcare
  • HUMARES GmbH
  • ICU Medical
  • MedicaP GmbH
  • Medtronic plc
  • Nihon Kohden
  • Nonin Medical Inc
  • Perimed AB
  • Philips Healthcare
  • Radiometer Medical ApS
  • SenTec AG
  • Shinse Electronics Group
  • Sophysa Ltd
  • Teva Pharmaceutical (Cephalon)
  • Vittamed

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Transcutaneous Oximetry Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Emphasis on Gas Purity and Equipment Protection Drives Demand for High-Performance Gas Filtration Solutions
    • Growth in Industrial Applications Such as Petrochemical, Power Generation, and Semiconductor Manufacturing Expands Market for Gas Filters
    • Increased Integration of Gas Filters in Gas Compression, Processing, and Distribution Systems Supports End-to-End Flow Purity
    • Advancements in Filter Media and Membrane Technologies Improve Filtration Efficiency, Pressure Drop, and Service Life
    • Expansion of Hydrogen Production and Fuel Cell Technologies Spurs Development of Specialized Filters for Ultra-High Purity Gases
    • Demand for Contaminant-Free Gas in Analytical Labs and Medical Facilities Boosts Market for Precision Inline Filters
    • OEM Emphasis on Compact and Modular Filter Designs Enhances Integration in Skid Packages and Tight Industrial Spaces
    • Growing Investment in Natural Gas and Biogas Infrastructure Drives Need for Coalescing and Particulate Gas Filters
    • Digital Monitoring and Differential Pressure Sensing Enable Predictive Maintenance and Filter Replacement Efficiency
    • Rising Use of Filters in Cryogenic Gas Processing and LNG Operations Supports Cryo-Compatible and High-Pressure Filter Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Transcutaneous Oximetry Systems Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Transcutaneous Oximetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Transcutaneous Oximetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Peripheral Vascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Peripheral Vascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Peripheral Vascular Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diabetic Foot Ulcers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diabetic Foot Ulcers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Diabetic Foot Ulcers Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Preterm Births Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Preterm Births Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Preterm Births Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • JAPAN
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CHINA
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • EUROPE
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Transcutaneous Oximetry Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Transcutaneous Oximetry Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • FRANCE
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • GERMANY
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Transcutaneous Oximetry Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Transcutaneous Oximetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • INDIA
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Transcutaneous Oximetry Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Transcutaneous Oximetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Transcutaneous Oximetry Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Transcutaneous Oximetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AFRICA
    • Transcutaneous Oximetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Transcutaneous Oximetry Systems by Application - Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Transcutaneous Oximetry Systems by Application - Percentage Breakdown of Value Sales for Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Transcutaneous Oximetry Systems by End-user - Hospitals End-User, Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Transcutaneous Oximetry Systems by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Clinics End-User and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION